Estimating the effect of the run‐in on the power of the physicians' health study
The DOI matches its Crossref record.
Abstract
In the Physicians' Health Study, a randomized, placebo‐controlled, double‐blind trial of aspirin in the reduction of cardiovascular mortality and beta‐carotene in decreasing cancer incidence, 33,223 subjects were eligible and willing to enter the trial. Instead of randomizing this group immediately, all participants received identical calendar packs that contained active aspirin and beta‐carotene placebo. Following an 18‐week run‐in, only 22,071 subjects who remained eligible and willing and had taken at least 2/3 of their pills were randomized. We estimated the effect of the run‐in as follows: pill taking compliance increased 20‐41 per cent; sample size decreased 34 per cent; duration of follow‐up decreased 7 per cent which resulted in a 7 per cent decrease in the expected event rate for the placebo group. To estimate these changes, we made assumptions about compliance and outcome risk for those excluded by the run‐in. Our conclusion, however, about the net effect of the run‐in on the power of the study remains constant across variations in a number of those assumptions. The power with the run‐in, with 22,071 good compliers was typically higher, and never more than negligibly lower, than the power without the run‐in, with 33,223 good and poor compliers. In addition, savings from enrolling 11,152 fewer subjects in the trial resulted from the use of the run‐in.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176.pub2 · Cited by 924
Sesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913
HPS2-THRIVE Collaborative Group, Haynes, R., Jiang, L., Hopewell, J. C., Li, J., Chen, F., Parish, S., Landray, M. J., Collins, R., Armitage, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht055 · Cited by 676
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) · The Lancet · doi:10.1016/s0140-6736(10)60310-8 · Cited by 558
Manson, J. E., Bassuk, S. S., Lee, I.-M., Cook, N. R., Albert, M. A., Gordon, D., Zaharris, E., MacFadyen, J. G., Danielson, E., Lin, J., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.009 · Cited by 557
Self-citationStrategies to improve recruitment to randomised trials
Treweek, S., Pitkethly, M., Cook, J., Fraser, C., Mitchell, E., Sullivan, F., Jackson, C., Taskila, T. K., & Gardner, H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub6 · Cited by 521
Gaziano, J. M., Glynn, R. J., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Sesso, H. D., & Buring, J. E. (2009) · JAMA · doi:10.1001/jama.2008.862 · Cited by 518
Self-citationStrategies to improve recruitment to randomised controlled trials
Treweek, S., Mitchell, E., Pitkethly, M., Cook, J., Kjeldstrøm, M., Johansen, M., Taskila, T. K., Sullivan, F., Wilson, S., Jackson, C., et al. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub5 · Cited by 378
Christen, W. G., Gaziano, J. M., & Hennekens, C. H. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00042-3 · Cited by 376
Self-citation(2010) · JAMA · doi:10.1001/jama.2010.840 · Cited by 327
“Potentially eligible participants entered a prerandomization run-in phase, which was intended chiefly to limit subsequent randomization to those likely to take the randomly allocated study treatment for several years.(18) Run-in treatment involved placebo vitamin tablets (and 20 mg simvastatin daily, which allowed bas…”
BackgroundSHARP Collaborative Group (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.08.012 · Cited by 319
Baseline Characteristics of Participants in the Women's Health Study
Rexrode, K. M., Lee, I.-M., Cook, N. R., Hennekens, C. H., & Buring, J. E. (2000) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460900318911 · Cited by 310
Self-citationBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176 · Cited by 302
Gaziano, J. M., Sesso, H. D., Christen, W. G., Bubes, V., Smith, J. P., MacFadyen, J., Schvartz, M., Manson, J. E., Glynn, R. J., & Buring, J. E. (2012) · JAMA · doi:10.1001/jama.2012.14641 · Cited by 269
Self-citationAntioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Evans, J. R., & Lawrenson, J. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000253.pub4 · Cited by 257
Sesso, H. D., Manson, J. E., Aragaki, A. K., Rist, P. M., Johnson, L. G., Friedenberg, G., Copeland, T., Clar, A., Mora, S., Moorthy, M. V., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac055 · Cited by 187
Bowman, L., Mafham, M., Stevens, W., Haynes, R., Aung, T., Chen, F., Buck, G., Collins, R., & Armitage, J. (2018) · American Heart Journal · doi:10.1016/j.ahj.2017.12.006 · Cited by 106
“By this process, many potential dropouts could be excluded before becoming part of the randomized comparison, with a consequent improvement in statistical sensitivity of the “intention-to-treat” analyses.(22) Randomization.”
BackgroundMRC/BHF Heart Protection Study Collaborative Group (2009) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-9-6 · Cited by 70
“Prior to randomization, many potential drop-outs were excluded during the run-in period or at the randomization visit in order to improve the statistical sensitivity of HPS to assess the efficacy of prolonged simvastatin [21].”
BackgroundSesso, H. D., Rist, P. M., Aragaki, A. K., Rautiainen, S., Johnson, L. G., Friedenberg, G., Copeland, T., Clar, A., Mora, S., Moorthy, M. V., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac056 · Cited by 51
Metadata
- Authors
- Lang, J. M., Buring, J. E., Rosner, B., Cook, N., & Hennekens, C. H.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 1991-10
- Volume
- 10
- Issue
- 10
- Pages
- 1585-1593
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W1974711414
- Cited by
- 99
- References
- 0
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.